John Alexander Kelly sold $61k of DTIL
Chief Financial Officer at PRECISION BIOSCIENCES INC. 15,213 shares at an average of $4.03, traded Jan 21, 2026, filed Jan 22, 2026.
Score components
- +22RoleCFO
- +7Trade size$61k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.8%, 3m +72.0%, 6m +72.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-003147, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | MOption exercise Common Stock10b5-1 | +3,888 | - | - | 81,186 | Jan 22, 2026 |
| Jan 20, 2026 | MOption exercise Common Stock10b5-1 | +13,900 | - | - | 95,086 | Jan 22, 2026 |
| Jan 20, 2026 | MOption exercise Common Stock10b5-1 | +26,575 | - | - | 121,661 | Jan 22, 2026 |
| Jan 21, 2026 | SOpen-market sale Common Stock10b5-1 | -15,213 | $4.03 | $61k | 106,448 | Jan 22, 2026 |
| Jan 20, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,888 | $0.00 | $0 | 0 | Jan 22, 2026 |
| Jan 20, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -13,900 | $0.00 | $0 | 13,901 | Jan 22, 2026 |
| Jan 20, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -26,575 | $0.00 | $0 | 26,575 | Jan 22, 2026 |
Related signals
Other insiders at PRECISION BIOSCIENCES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | PRECISION BIOSCIENCES INC | Stanley Frankel director | $6,000 1,000 shares | +2% | |
| 38Weak | PRECISION BIOSCIENCES INC | Melinda Brown director | $7,116 1,135 shares | +3% | |
| 41Moderate | PRECISION BIOSCIENCES INC | Geno J Germano director | $16k 2,609 shares | +6% | |
| 14Weak | PRECISION BIOSCIENCES INC | Michael Amoroso President and CEO | $79k 20,559 shares | -8% | |
| 7Weak | PRECISION BIOSCIENCES INC | John Alexander Kelly Chief Financial Officer | $31k 8,149 shares | -6% | |
| 0Weak | PRECISION BIOSCIENCES INC | J. Jefferson Smith Chief Research Officer | $19k 4,925 shares | -4% | |
| 0Weak | PRECISION BIOSCIENCES INC | Dario Scimeca General Counsel and Secretary | $19k 4,925 shares | -8% | |
| 21Weak | PRECISION BIOSCIENCES INC | Michael Amoroso President and CEO | $145k 34,799 shares | -15% | |
| 1Weak | PRECISION BIOSCIENCES INC | J. Jefferson Smith Chief Research Officer | $41k 10,200 shares | -8% | |
| 6Weak | PRECISION BIOSCIENCES INC | Dario Scimeca General Counsel and Secretary | $36k 8,854 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.